CYP2A7
قراءة متعمقة

Smith BD، Sanders JL، Porubsky PR، وآخرون (2007). "Structure of the human lung cytochrome P450 2A13". J. Biol. Chem. ج. 282 ع. 23: 17306–13. DOI:10.1074/jbc.M702361200. PMID:17428784.{{استشهاد بدورية محكمة}}:  صيانة الاستشهاد: دوي مجاني غير معلم (link)
Wang HH، Liao YW، Chiang HL، وآخرون (2009). "Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population". Pharmacogenomics. ج. 10 ع. 3: 359–74. DOI:10.2217/14622416.10.3.359. PMID:19290787.
Fernandez-Salguero P، Gonzalez FJ (1995). "The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis". Pharmacogenetics. ج. 5 ع. Special Issue: S123–8. DOI:10.1097/00008571-199512001-00013. PMID:7581481.
Cauffiez C، Lo-Guidice JM، Quaranta S، وآخرون (2004). "Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility". Biochem. Biophys. Res. Commun. ج. 317 ع. 2: 662–9. DOI:10.1016/j.bbrc.2004.03.092. PMID:15063809.
Timofeeva MN، Kropp S، Sauter W، وآخرون (2009). "CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences". Carcinogenesis. ج. 30 ع. 7: 1161–9. DOI:10.1093/carcin/bgp102. PMID:19414505.
Smith G، Stubbins MJ، Harries LW، Wolf CR (1998). "Molecular genetics of the human cytochrome P450 monooxygenase superfamily". Xenobiotica. ج. 28 ع. 12: 1129–65. DOI:10.1080/004982598238868. PMID:9890157.
Saito A، Kawamoto M، Kamatani N (2009). "Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects". J. Hum. Genet. ج. 54 ع. 6: 317–23. DOI:10.1038/jhg.2009.31. PMID:19343046.
He XY، Shen J، Ding X، وآخرون (2004). "Identification of critical amino acid residues of human CYP2A13 for the metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen". Drug Metab. Dispos. ج. 32 ع. 12: 1516–21. DOI:10.1124/dmd.104.001370. PMID:15333516.
Nelson DR، Zeldin DC، Hoffman SM، وآخرون (2004). "Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants". Pharmacogenetics. ج. 14 ع. 1: 1–18. DOI:10.1097/00008571-200401000-00001. PMID:15128046.
He XY، Shen J، Hu WY، وآخرون (2004). "Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation". Arch. Biochem. Biophys. ج. 427 ع. 2: 143–53. DOI:10.1016/j.abb.2004.03.016. PMID:15196988.
Herr D، Bettendorf H، Denschlag D، وآخرون (2006). "Cytochrome P2A13 and P1A1 gene polymorphisms are associated with the occurrence of uterine leiomyoma". Arch. Gynecol. Obstet. ج. 274 ع. 6: 367–71. DOI:10.1007/s00404-006-0201-8. PMID:16835796.
Song DK، Xing DL، Zhang LR، وآخرون (2009). "Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China". Cancer Detect. Prev. ج. 32 ع. 5–6: 416–23. DOI:10.1016/j.cdp.2009.02.003. PMID:19303722.
Fujieda M، Yamazaki H، Kiyotani K، وآخرون (2003). "Eighteen novel polymorphisms of the CYP2A13 gene in Japanese". Drug Metab. Pharmacokinet. ج. 18 ع. 1: 86–90. DOI:10.2133/dmpk.18.86. PMID:15618722.
Wang H، Tan W، Hao B، وآخرون (2003). "Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK". Cancer Res. ج. 63 ع. 22: 8057–61. PMID:14633739.
Cheng XY، Chen GL، Zhang WX، وآخرون (2004). "Arg257Cys polymorphism of CYP2A13 in a Chinese population". Clin. Chim. Acta. ج. 343 ع. 1–2: 213–6. DOI:10.1016/j.cccn.2004.01.017. PMID:15115698.
D'Agostino J، Zhang X، Wu H، وآخرون (2008). "Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers". Drug Metab. Dispos. ج. 36 ع. 11: 2316–23. DOI:10.1124/dmd.108.022822. PMC:2597635. PMID:18669584.
Cauffiez C، Pottier N، Tournel G، وآخرون (2005). "CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations". Xenobiotica. ج. 35 ع. 7: 661–9. DOI:10.1080/00498250500202171. PMID:16316926.
Mohelnikova-Duchonova B، Vrana D، Holcatova I، وآخرون (2010). "CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk". Pancreas. ج. 39 ع. 2: 144–8. DOI:10.1097/MPA.0b013e3181bab6c2. PMID:19812523.
Jiang JH، Jia WH، Chen HK، وآخرون (2004). "Genetic polymorphisms of CYP2A13 and its relationship to nasopharyngeal carcinoma in the Cantonese population". J Transl Med. ج. 2 ع. 1: 24. DOI:10.1186/1479-5876-2-24. PMC:455696. PMID:15222883.{{استشهاد بدورية محكمة}}:  صيانة الاستشهاد: دوي مجاني غير معلم (link)
Young RP، Hopkins RJ، Hay BA، وآخرون (2009). "A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers". Postgrad Med J. ج. 85 ع. 1008: 515–24. DOI:10.1136/pgmj.2008.077107. PMID:19789190.
| 0 | 1 |
| --- | --- |
معرفات كيميائية:  قاعدة بيانات التتابع المرجعي (RefSeq RNA): XM_047438279  
| ع ن جينات الكروموسوم 19 | ع ن جينات الكروموسوم 19 |
| --- | --- |